the development of pre-eclampsia and to relate leptin concentrations to other clinical markers of the disease. Leptin concentrations have been found to be elevated in cross-sectional studies of established pre-eclampsia. Circulating concentrations of leptin were measured in a Materials and methods cross-sectional study to confirm these findings (19 women
In the cross-sectional study, fasting venous blood samples were with pre-eclampsia and 13 normal pregnant controls) and 
pregnant controls). In the cross-sectional study, plasma
In the longitudinal study, samples were obtained from seven leptin concentrations were significantly greater in women nulliparous women with normal uncomplicated pregnancies and eight with pre-eclampsia than in normal controls (P ⍧ 0.001).
women who subsequently developed pre-eclampsia. The aim of the In the longitudinal study, it was found that circulating longitudinal study was to establish the timing of the increase in circulating leptin concentrations in pregnancies destined to be leptin concentrations rose gradually to 32 weeks and complicated by pre-eclampsia. In order to recruit the appropriate thereafter declined slightly in normals. The concentrations number of subjects for the study, a power calculation was performed in women destined to develop pre-eclampsia were consistusing the cross-sectional data. The mean SD of the data was 4.9 and ently higher from 20 weeks gestation (P ⍧ 0.04-0.003) the difference between the groups 11.6. In order to be able to show and, in contrast to the normal controls, rose markedly a significant difference in leptin concentrations with established prefrom 32 weeks as pre-eclampsia developed. This study eclampsia at P ϭ 0.05 and with a power of 95%, it was calculated confirms that plasma leptin concentrations are increased that a sample size of seven in each arm would be needed. prein established pre-eclampsia and reports for the first time eclampsia was defined according to the criteria of hypertension, that leptin concentrations are elevated before pre-eclampsia proteinuria, hyperuricaemia and reversal of hypertension and prois clinically evident. teinuria after the pregnancy. Hypertension was defined as an increase Introduction protein excretion in 24 h (Davey and MacGillivray, 1988) . Exclusion criteria were diabetes, chronic hypertension, known history of peri- concentrations in normal pregnancy and pre-eclampsia. The points represent plasma leptin concentrations (ng/l), and the bars mean values. P ϭ 0.001. 1996). The assay employed a polyclonal (rabbit) antibody raised against recombinant human leptin. Standards and I -125 -tracer were also made from recombinant human leptin (Ma et al., 1996) . The by log-transformation and comparisons made using an unpaired t-test.
Booking BMI (kg/m 2 ) 2 4 Ϯ 3.9 24 Ϯ 2.6 Booking systolic BP (mmHg) 107 Ϯ 6.0 114 Ϯ 6.0
The rest of the cross-sectional and all of the longitudinal data were measures. Pearson's correlation coefficients were calculated and a There were no statistically significant differences between the two groups.
multiple regression analysis performed to determine which of the BMI ϭ body mass index; BP ϭ blood pressure.
variables were independently related to plasma leptin concentrations. For all comparisons, statistical significance was defined as P Ͻ 0.05. The Statistical Package for Social Sciences (SPSS), version 8, was used for statistical analysis.
Results
The demographic and clinical characteristics of the subjects taking part in the cross-sectional study are shown in Table I . As expected from the recruitment criteria, the pre-eclampsia group had lower platelet counts (P ϭ 0.002), higher systolic and diastolic blood pressures (both P ϭ 0.001) and higher plasma uric acid concentrations (P ϭ 0.04). There was no significant difference in serum creatinine between the two groups. Plasma leptin was significantly increased in the preeclampsia group [27.13, 14.4-49.5 (median, range)] compared to the normal controls [11.7, 7.4-19 (median, range)] (P ϭ 0.001, Figure 1 ).
Figure 2. Longitudinal changes in plasma leptin in normal pregnant
The demographic and clinical characteristics of the subjects controls (o) and pre-eclampsia group (s). The points represent taking part in the longitudinal study are shown in Table II . In mean Ϯ SD. There were no data available for the pre-eclampsia women destined to develop pre-eclampsia, leptin concentragroup after 36 weeks as they all required delivery before 38 weeks. P ϭ 0.0001, analysis of variance for repeated measures.
tions were consistently higher than normal controls between 20 and 36 weeks gestation. In the normal controls, circulating leptin concentrations rose gradually to 32 weeks and thereafter higher between 20 and 36 weeks gestation in the women who developed pre-eclampsia compared to normal controls (P ϭ declined slightly. In contrast, the concentrations in the preeclampsia group rose markedly from 32 weeks as the disease 0.0001, ANOVA for repeated measures). In the longitudinal study, positive correlations were found between the pattern of developed (Figure 2) . Leptin concentrations were significantly change of plasma leptin and both systolic blood pressure (r ϭ leptin and uric acid concentrations in the pre-eclampsia group. This relationship may have several explanations. Both leptin 0.94, P ϭ 0.005 versus r ϭ 0.69, not significant, NS) and diastolic blood pressure (r ϭ 0.88, P ϭ 0.02 versus r ϭ 0.74, and urate may be markers of pre-eclampsia and their strong relationship may simply be a reflection of this. In non-pregnant NS) in pre-eclampsia group.
Leptin concentrations in the cross-sectional group and condiabetics, leptin is closely related to urate concentrations, independent of BMI and blood pressure (Fruehwald-Schultes centrations at 36 weeks were correlated with clinical and biochemical parameters. In the pre-eclampsia group, significant et al., 1999) , which suggests that one may affect the circulating concentrations of the other. Leptin may contribute to the correlations were observed between plasma leptin and uric acid concentrations (r ϭ 0.92, P ϭ 0.01 versus r ϭ 0.56, NS) increased uric acid concentrations as plasma uric acid concentrations are increased by oxidative stress (Davidge, 1998) and BMI (r ϭ 0.6, P ϭ 0.02 versus r ϭ 0.09, NS) for pre-eclampsia and normal pregnancy respectively. Multiple and leptin has been reported to induce oxidative stress in cultured human endothelial cells (Bouloumie et al., 1999) . regression analysis found that only uric acid and BMI were independently related to plasma leptin concentrations in the Thus, there are several possible explanations for the higher leptin concentrations in pregnancies destined to develop prepre-eclampsia.
eclampsia. Moreover, they may play a role in the development of pre-eclampsia. This possibility requires further evaluation.
Discussion
Although in this study it was observed that leptin concentrations in pre-eclampsia were independently related to maternal The data confirm that leptin concentrations are higher in established pre-eclampsia (McCarthy et al., 1999) and show pre-pregnancy BMI in the pre-eclampsia group, other studies have failed to observe such a relationship during normal for the first time that they are elevated before pre-eclampsia is clinically evident. In addition, it was found that whereas in pregnancy (Highman et al., 1998) and pre-eclampsia (Williams et al., 1999) . This may be because weight gain during pregnormal pregnancy leptin concentrations decline late in the third trimester, and were in fact slightly lower than previously nancy is not solely due to fat deposition (the most important factor for regulating plasma leptin in non-pregnant women). reported (Sivan et al., 1998) , a rapid increase occurs in the same period in those subjects who developed pre-eclampsia.
There was no significant difference in haematocrit values and plasma creatinine concentrations between the two groups. The higher concentrations of leptin in pregnancies complicated by pre-eclampsia are consistent with observations that placental Thus, it seems unlikely that haemoconcentration or impaired renal function, which are recognized pathophysiological comexpression of leptin mRNA is up-regulated in pre-eclamptic placentae (Mise et al., 1998) . This group also found that the ponents of pre-eclampsia, contributed to the high leptin observed in the disease. Although the number of patients in expression of leptin by the human trophoblast cell line (BeWo cell line) was significantly increased when cultured under this study is limited, the highly significant statistical difference between the groups favours a true biological finding. hypoxic conditions (5% oxygen) compared with standard conditions (Mise et al., 1998) . Placental ischaemia could In summary, the data confirm that plasma leptin concentrations are higher in established pre-eclampsia. This study has therefore explain the rapid increase in leptin concentrations during late third trimester in pre-eclampsia. Alternatively, the shown for the first time that this increase pre-dates the development of pre-eclampsia, the occurrence of which is increase may represent an adaptive response by the fetoplacental unit to impaired placental perfusion, mounted in an associated with a further marked increase in plasma leptin concentrations. The mechanisms responsible for this increase attempt to meet the energy requirements of the fetus. Finally, there is evidence that inflammatory mediators increase plasma and the role played by leptin in the development of preeclampsia require further study. leptin concentrations (Lord et al., 1998) , and, in pre-eclampsia, circulating concentrations of the inflammatory cytokines such as tumour necrosis factor-α (TNFα) and interleukin-6 (IL-6)
